Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Share Save Share Save Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019L
Harada, Hideyuki; Hata, Akito; Konno, Masahiro; Mamesaya, Nobuaki; Nakamatsu, Kiyoshi; Haratani, Koji; Yamamoto, Takaya; Saito, Ryota; Mayahara, Hiroshi; Kokubo, Masaki; Sato, Yuki; Imano, Nobuki; Masuda, Takeshi; Fukuda, Haruyuki; Sado, Toshikatsu; Yoshimura, Kenichi; Nishimura, Yasumasa; Nakagawa, Kazuhiko; Okamoto, Isamu; Yamamoto, Nobuyuki Share Save Share Save Share Save Final Survival Outcomes With Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated EGFR-Mutated Metastatic NSCLC: RELAY Japanese SubsetNishio, Makoto; Seto, Takashi; Reck, Martin; Garon, Edward B.; Nishio, Kazuto; Kasahara, Kazuo; Nishino, Kazumi; Satouchi, Miyako; Yoh, Kiyotaka; Hayashi, Hidetoshi; Sakai, Kazuko; Enatsu, Sotaro; Frimodt-Moller, Bente; Matsui, Tomoko; Varughese, Sunoj Chacko; Carlsen, Michelle; Visseren-Grul, Carla; Nakagawa, Kazuhiko Share Save RELAY: Final Overall Survival for Erlotinib Plus Ramucirumab or Placebo in Untreated, EGFR-Mutated Metastatic NSCLCNakagawa, Kazuhiko; Garon, Edward B.; Seto, Takashi; Nishio, Makoto; Aix, Santiago Ponce; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Nishino, Kazumi; Yoh, Kiyotaka; Shih, Jin-Yuan; Chik, Jeannie Y. K.; Moro-Sibilot, Denis; Puri, Tarun; Varughese, Sunoj Chacko; Frimodt-Moller, Bente; Visseren-Grul, Carla; Reck, Martin Share Save Efficacy in patients with EGFR-positive non-small-cell lung cancer treated with dacomitinib who had skin adverse events: post hoc analyses from ARCHER 1050Pu, Xingxiang; Li, Juan; Zhang, Bo; Zhang, Jinyao; Mok, Tony S.; Nakagawa, Kazuhiko; Rosell, Rafael; Cheng, Ying; Zhou, Xiangdong; Miglorino, Maria Rita; Niho, Seiji; Lee, Ki Hyeong; Corral, Jesus; Pluzanski, Adam; Li, Junling; Linke, Rolf; Pan, Fang; Tang, Yiyun; Tan, Weiwei; Wu, Lin Share Save Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapyMiyamoto, Atsushi; Michimae, Hirofumi; Nakahara, Yasuharu; Akagawa, Shinobu; Nakagawa, Kazuhiko; Minegishi, Yuji; Ogura, Takashi; Hontsu, Shigeto; Date, Hiroshi; Takahashi, Kazuhisa; Homma, Sakae; Kishi, Kazuma; Nakahara, Y.; Ohta, K.; Gemma, A.; Nishizaka, Y.; Ogura, T.; Kimura, H.; Nishi, K.; Nakamura, M.; Yokomura, K.; Taniguchi, H.; Tomii, K.; Shindo, J.; Sato, K.; Taguchi, Y.; Takahashi, H.; Takizawa, H.; Homma, S.; Nakamura, S.; Yoshimura, K.; Usui, K.; Ichikado, K.; Bessyo, A.; Sugiyama, H.; Hasegawa, Y.; Nakamura, H.; Sagara, H.; Ube, K.; Nomura, F.; Kiura, K.; Yoshiike, F.; Takahashi, K.; Kita, T.; Sakai, H.; Bando, M.; Matsumoto, T.; Inoue, T.; Kijima, T.; Mukae, H.; Masuda, N.; Matsumoto, N.; Sakamaki, F.; Kamimura, M.; Takise, A.; Kishaba, T.; Nishioka, Y.; Kashiwabara, K.; Yamamoto, A.; Fujiuchi, S.; Shingyoji, M.; Hanaoka, M.; Tominaga, S.; Kadota, J.; Kasahara, T.; Motegi, M.; Harada, T.; Ishikawa, S.; Suda, T.; Tomizawa, Y.; Hayashi, R.; Shinoda, M.; Terada, M.; Jin, Y.; Shikama, Y.; Kikuchi, T.; Kido, K.; Yokoyama, A.; Fuke, S.; Nagase, H.; Tanaka, H.; Hizawa, N.; Miyazaki, K.; Ikushima, S.; Sakai, N.; Hoshino, T.; Mishima, M.; Ohnishi, H.; Imai, H.; Nagashima, S.; Kojima, E.; Ohishi, S.; Ohe, Y.; Iwakami, S.; Mineshita, M.; Komase, Y.; Harada, H.; Imokawa, S.; Watanabe, H.; Ichiki, M.; Kuwano, K.; Takahashi, N.; Chonabayashi, N.; Hisada, T.; Yoshida, M.; Hirata, K.; Watanabe, K.; Sugino, Y.; Yoshioka, S.; Tomioka, H.; Aoshima, M.; Sugimoto, Y.; Ichinose, M.; Tamaki, S.; Tsuchiya, M.; Katayama, H.; Okochi, Y.; Tanaka, H.; Ogata, K.; Tsuburai, T.; Honda, I. Share Save Soluble immune checkpoint factors reflect exhaustion of antitumor immunity and response to PD-1 blockadeHayashi, Hidetoshi; Chamoto, Kenji; Hatae, Ryusuke; Kurosaki, Takashi; Togashi, Yosuke; Fukuoka, Kazuya; Coto, Megumi; Chiba, Yasutaka; Tomida, Shuta; Ota, Takayo; Haratani, Koji; Takahama, Takayuki; Tanizaki, Junko; Yoshida, Takeshi; Iwasa, Tsutomu; Tanaka, Kaoru; Takeda, Masayuki; Hirano, Tomoko; Yoshida, Hironori; Ozasa, Hiroaki; Sakamori, Yuichi; Sakai, Kazuko; Higuchi, Keiko; Uga, Hitoshi; Suminaka, Chihiro; Hirai, Toyohiro; Nishio, Kazuto; Nakagawa, Kazuhiko; Honjo, Tasuku Share Save Association between skin toxicity and ef fi cacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCMWatanabe, S.; Yoshioka, H.; Sakai, H.; Hotta, K.; Takenoyama, M.; Yamada, K.; Sugawara, S.; Takiguchi, Y.; Hosomi, Y.; Tomii, K.; Niho, S.; Nishio, M.; Kato, T.; Takahashi, T.; Ebi, H.; Aono, M.; Yamamoto, N.; Ohe, Y.; Nakagawa, K. Share Save The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung AdenocarcinomaKanemura, Hiroaki; Yokoyama, Toshihide; Nakajima, Ryu; Nakamura, Atsushi; Kuroda, Hiroaki; Kitamura, Yoshitaka; Shoda, Hiroyasu; Mamesaya, Nobuaki; Miyata, Yoshihiro; Okamoto, Tatsuro; Okishio, Kyoichi; Oki, Masahide; Sakairi, Yuichi; Chen-Yoshikawa, Toyofumi Fengshi; Aoki, Tadashi; Ohira, Tatsuo; Matsumoto, Isao; Ueno, Kiyonobu; Miyazaki, Takuro; Matsuguma, Haruhisa; Yokouchi, Hideoki; Otani, Tomoyuki; Ito, Akihiko; Sakai, Kazuko; Chiba, Yasutaka; Nishio, Kazuto; Yamamoto, Nobuyuki; Okamoto, Isamu; Nakagawa, Kazuhiko; Takeda, Masayuki Share Save Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancerHaratani, Koji; Nakamura, Atsushi; Mamesaya, Nobuaki; Sawa, Kenji; Shiraishi, Yoshimasa; Saito, Ryota; Tanizaki, Junko; Tamura, Yosuke; Hata, Akito; Tsuruno, Kosuke; Sakamoto, Tomohiro; Teraoka, Shunsuke; Oki, Masahide; Watanabe, Hiroshi; Tokito, Takaaki; Nagata, Kenji; Masuda, Takeshi; Nakamura, Yasushi; Sakai, Kazuko; Chiba, Yasutaka; Ito, Akihiko; Nishio, Kazuto; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko; Hayashi, Hidetoshi Share Save The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective studyKurosaki, Takashi; Chamoto, Kenji; Suzuki, Shinichiro; Kanemura, Hiroaki; Mitani, Seiichiro; Tanaka, Kaoru; Kawakami, Hisato; Kishimoto, Yo; Haku, Yasuharu; Ito, Katsuhiro; Sato, Toshiyuki; Suminaka, Chihiro; Yamaki, Mami; Chiba, Yasutaka; Yaguchi, Tomonori; Omori, Koichi; Kobayashi, Takashi; Nakagawa, Kazuhiko; Honjo, Tasuku; Hayashi, Hidetoshi Share Save A Phase 2 Single-Arm Study of Osimertinib for Radiotherapy-Naive Central Nervous System Metastasis NSCLC: Results for the First-Line Cohort of the OCEAN Study (LOGIK 1603/WJOG 9116L)Wakuda, Kazushige; Yamaguchi, Hiroyuki; Kenmotsu, Hirotsugu; Fukuda, Minoru; Ito, Kentaro; Tsuchiya-Kawano, Yuko; Tanaka, Kentaro; Harada, Taishi; Nakatani, Yuki; Miura, Satoru; Yokoyama, Toshihide; Nakamura, Tomomi; Izumi, Miiru; Nakamura, Atsushi; Ikeda, Satoshi; Takayama, Koichi; Yoshimura, Kenichi; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki; Sugio, Kenji Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
